Glimifact MV 1mg/500mg/0.3mg Tablet
Marketer
Tripada Lifecare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimifact MV 1mg/500mg/0.3mg Tablet
Diabex Trio 1mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage will be determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan involving a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Learn to recognize these signs and treat accordingly. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of cardiovascular disease should inform their physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Glimifact MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimifact MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimifact MV 1mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Glimifact MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimifact MV 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimifact MV 1mg/500mg/0.3mg Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Glimifact MV 1mg/500mg/0.3mg Tablet works:
Each Glimifact MV tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Glimifact MV 1mg/500mg/0.3mg Tablet is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glimifact MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimifact MV 1mg/500mg/0.3mg tablets while breastfeeding is likely unsafe. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimifact MV 1mg/500mg/0.3mg tablets is inadvisable for individuals with kidney impairment and should be prevented. Medical advice is essential. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Individuals with liver impairment should use Glimifact MV 1mg/500mg/0.3mg tablets cautiously, as dose modification may be necessary. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, this medication is unsuitable for patients with severe hepatic dysfunction.
What if you forget to take Glimifact MV 1mg/500mg/0.3mg Tablet :
Should you forget to take a Glimifact MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimifact MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently